Emerging Infectious Diseases (Sep 2020)

Persistence of Severe Acute Respiratory Syndrome Coronavirus 2 in Aerosol Suspensions

  • Alyssa C. Fears,
  • William B. Klimstra,
  • Paul Duprex,
  • Amy Hartman,
  • Scott C. Weaver,
  • Kenneth S. Plante,
  • Divya Mirchandani,
  • Jessica Ann Plante,
  • Patricia V. Aguilar,
  • Diana Fernández,
  • Aysegul Nalca,
  • Aysegul Totura,
  • David Dyer,
  • Brian Kearney,
  • Matthew Lackemeyer,
  • J. Kyle Bohannon,
  • Reed Johnson,
  • Robert F. Garry,
  • Doug S. Reed,
  • Chad J. Roy

DOI
https://doi.org/10.3201/eid2609.201806
Journal volume & issue
Vol. 26, no. 9
pp. 2168 – 2171

Abstract

Read online

We aerosolized severe acute respiratory syndrome coronavirus 2 and determined that its dynamic aerosol efficiency surpassed those of severe acute respiratory syndrome coronavirus and Middle East respiratory syndrome. Although we performed experiment only once across several laboratories, our findings suggest retained infectivity and virion integrity for up to 16 hours in respirable-sized aerosols.

Keywords